Document Status

This document has been corrected

Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression

10.1007/s00261-020-02731-z

Published Online: 2020-09-12

Journal: Abdominal Radiology•Publisher: Springer Science and Business Media LLC

Authors: Aboelyazid Elkilany•Andreas Fischer•Dominik Geisel•Timm Denecke•Tobias Müller

This document has been corrected

Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression

10.1007/s00261-020-02731-z

Published Online: 2020-09-12

Journal: Abdominal Radiology

Authors: Aboelyazid Elkilany•Andreas Fischer•Dominik Geisel•Timm Denecke•Tobias Müller

NOW

2021-07-05•Correction

Correction to: Gadoxetic acid‑enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression

10.1007/s00261-021-03155-z

* information provided by CrossRef

2021-07-05•Correction

10.1007/s00261-021-03155-z

* information provided by CrossRef

2020-09-12•Published